Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial.

A WickA SanderM KochM BendszusS CombsT HautA DormannS WalterM PertzJ Merkle-LockN SelkrigR LimprechtL BaumannM KieserF SahmU SchlegelF WinklerM PlattenWolfgang WickT Kessler

Published in: BMC cancer (2022)

Clinicaltrials.gov NCT05331521 . EudraCT 2018-005027-16.

Keyphrases

newly diagnosed
high grade
phase iii
study protocol
phase ii
clinical trial
open label
randomized controlled trial
double blind